Hudson Global, Inc., represented by the ticker symbol HSON, is a prominent player in the total talent solutions industry, operating under the Hudson RPO brand. The company specializes in delivering customized recruitment outsourcing and comprehensive talent solutions to organizations across the globe. Hudson Global's approach is centered on developing tailored talent solutions that cater to its clients' strategic growth objectives. The company's core business activities encompass a global presence, with direct operations in fourteen countries....
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 216.83 Bn | 33.00 | 4.96 | 35.68 Bn |
| 2 | DHR | Danaher Corp /De/ | 162.47 Bn | 46.38 | 6.69 | 16.86 Bn |
| 3 | IDXX | Idexx Laboratories Inc /De | 56.88 Bn | 55.36 | 13.65 | 1.09 Bn |
| 4 | A | Agilent Technologies, Inc. | 39.82 Bn | 32.64 | 5.87 | 3.41 Bn |
| 5 | IQV | Iqvia Holdings Inc. | 38.85 Bn | 30.28 | 2.44 | 15.19 Bn |
| 6 | NTRA | Natera, Inc. | 31.32 Bn | -101.29 | 14.80 | 0.18 Bn |
| 7 | MTD | Mettler Toledo International Inc/ | 28.99 Bn | 34.68 | 7.35 | 2.21 Bn |
| 8 | WAT | Waters Corp /De/ | 22.92 Bn | 35.32 | 7.38 | 1.49 Bn |
| Metric | Value | Industry | Percentile |
|---|---|---|---|
| EV to Assets | 0.14 | 2.69 | |
| EV to Cash from Ops. | -12.20 | 18.14 | |
| EV to Debt | 0.73 | 52.51 | |
| EV to EBIT | -4.86 | 19.22 | |
| EV to EBITDA | -7.69 | 4.35 | |
| EV to Free Cash Flow [EV/FCF] | -8.90 | 2.84 | |
| EV to Market Cap | 0.51 | 1.52 | |
| EV to Revenue | 0.11 | 4.79 | |
| Price to Book Value [P/B] | 0.49 | 1.34 | |
| Price to Earnings [P/E] | -6.83 | 22.02 |
| Metric | Value | Industry | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio | -72.54 | -1.96 | |
| Dividend Payout Ratio % | 0.00 | 2.83 | |
| Dividend per Basic Share | 0.00 | 0.19 | |
| FCF Dividend Payout Ratio % | 0.00 | 1.92 | |
| Interest Coverage | 25.67 | -126.58 |
| Metric | Value | Industry | Percentile |
|---|---|---|---|
| Capex Growth (1y) % | -796.49 | -31.50 | |
| Cash and Equivalents Growth (1y) % | 1.75 | 21.37 | |
| Dividend Growth (1y) % | 0.00 | 0.24 | |
| EBIAT Growth (1y) % | -37.64 | -55.24 | |
| EBITDA Growth (1y) % | 37.72 | -447.96 | |
| EBIT Growth (1y) % | 12.37 | -40.50 | |
| EBT Growth (1y) % | 11.60 | -70.94 | |
| EPS Growth (1y) % | -36.84 | -70.02 | |
| FCF Growth (1y) % | -23.82 | 56.33 | |
| Gross Profit Growth (1y) % | 6.03 | 185.11 |
| Metric | Value | Industry | Percentile |
|---|---|---|---|
| Asset Utilization Ratio | 1.27 | 0.56 | |
| Cash Payout Ratio | 0.00 | 0.01 | |
| Cash Ratio | 0.51 | 1.21 | |
| Current Ratio | 2.07 | 2.64 | |
| Debt to Equity Ratio | 0.34 | -0.80 | |
| Interest Cover Ratio | 25.67 | -126.58 | |
| Times Interest Earned | 25.67 | -126.58 |
| Metric | Value | Industry | Percentile |
|---|---|---|---|
| EBITDA Margin % | -1.30 | -129.91 | |
| EBIT Margin % | -2.33 | -156.71 | |
| EBT Margin % | -2.24 | -162.23 | |
| Gross Margin % | 49.20 | 47.70 | |
| Net Profit Margin % | -3.30 | -189.30 |